Christopher Liu Score: 27
Analyst at
Loop Capital Markets,
Leerink Partners
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-5.8%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
40%
2 W / 3 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
67%
2 W / 1 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 3 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 3 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
25%
1 W / 3 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
40%
2 W / 3 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 28, 2026 |
Sensei Biotherapeutics Inc
SNSE
|
BUY |
$50.00
Est. +200%
|
$16.65 | $21.50 |
Pending
|
$13.00
-21.9%
|
| Nov 19, 2024 |
Arvinas Inc
ARVN
|
BUY |
$62.00
Est. +149%
|
$24.94 | $26.94 |
Miss
|
$7.58
-69.6%
|
| Oct 16, 2024 |
Exelixis Inc
EXEL
|
BUY |
$28.50
Est. 0%
|
$28.50 | $49.40 |
Target Met
|
$53.13
+86.4%
|
| Apr 01, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$110.00
Est. +46%
|
$75.09 | $113.51 |
Target Met
|
$123.25
+64.1%
|
| Jun 10, 2022 |
Cogent Biosciences Inc
COGT
|
BUY |
$15.00
Est. +40%
|
$10.74 | - | - |
$33.10
+208.2%
|
Sensei Biotherapeutics Inc
SNSE
May 28, 2026
Signal & Target
BUY
$50.00
Start Price
$16.65
Best Price (1Y)
$21.50
Current Price
$13.00
Return
-21.9%
Arvinas Inc
ARVN
Nov 19, 2024
Signal & Target
BUY
$62.00
Start Price
$24.94
Best Price (1Y)
$26.94
Current Price
$7.58
Return
-69.6%
Exelixis Inc
EXEL
Oct 16, 2024
Signal & Target
BUY
$28.50
Start Price
$28.50
Best Price (1Y)
$49.40
Current Price
$53.13
Return
+86.4%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Apr 01, 2024
Signal & Target
BUY
$110.00
Start Price
$75.09
Best Price (1Y)
$113.51
Current Price
$123.25
Return
+64.1%
Cogent Biosciences Inc
COGT
Jun 10, 2022
Signal & Target
BUY
$15.00
Start Price
$10.74
Best Price (1Y)
-
Current Price
$33.10
Return
+208.2%